A Pharmacokinetics Study of Intravenous Ascorbic Acid

• Status: Completed
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a Phase 1, single-dose study to evaluate the pharmacokinetics of intravenous Ascorbic Acid.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: McGuff Pharmaceuticals, Inc.
• Treatments: Ascorbic Acid

Criteria

Inclusion Criteria:

• Is between the ages of 18 and 45 years, inclusive.

• Has a body mass index (BMI) between 18 and 32 kg/m2.

• Of sound health and has the ability to understand the requirements of the study and is willing to comply with all study requirements and procedures.

Exclusion Criteria:

• Participates in activities that would not allow accurate evaluation of the pharmacokinetics of Ascorbic Acid

• Medical or physical conditions that would not allow safe participation and/or accurate evaluation of the pharmacokinetics of Ascorbic Acid

• Has participated in an investigational drug study within the 30 days prior to CRU admission.